Core-antigen and RNA of hepatitis C virus in sera samples of patients with antibodies to virus Core-antigen

The expediency of studying a direct marker of infection, caused by hepatitis C virus (HCV), Core antigen (Ag-Core), as well as the importance of only detecting antibodies to Ag-Core (Ab-Core) antigen, is just being studied at the present time. The aim of this study was to identify Ag-Core and HCV RNA in blood sera samples obtained from patients with Ab-Core which are found in enzyme-linked immunosorbent assay (ELISA) with different optical density (OD). Materials and methods. Separate and joint Ab-HCV and Ag-Core identification in patients’ blood sera samples was carried out with ELISA test systems. The positivity coefficient (PC), also known as S/Co, was calculated as the ratio of a sample OD to the cut-off OD. HCV RNA was determined by using PCR with both electrophoretic and real-time detection of reaction products. In some samples HCV genotype has been defined. Results and conclusions. In our study the joint research of Ag-Core and Ab-HCV hasn 't improved the laboratory diagnostics of HCV infection compared with ELISA screening intended only for Ab-HCV identification. Contrary to this, Ag-Core identification has proved to be expedient in sera samples groups with different Ab-Core HCV S/Co. In a group of samples with Ab-Core S/Co > 15 Ag-Core is found 7 times as often as in those with low (< 6.5) Ab-Core S/Co (66.6 and 8.82 % respectively; p < 0.005). HCV RNA with a concentration higher than 3.8 * 10⁵ ME/ml is found in 75 % of samples with high Ag-Core (> 11) and AT-Core (> 15) S/Co. HCV RNA with a low concentration (< 300 ME/ml) is found in 20 % of samples with low Ab-Core S/Co (< 6.5) which also contain Ag-Core with low S/Co (< 3). Apparently, patients with Ag-Core as the only marker of HCV infection need to be under dynamic laboratory and clinical observation.

Core-антиген ВГС, HCV Core-antigen, RNA HCV, ELISA, screening

1. СП 3.1.3112-13 «Профилактика вирусного гепатита С».

2. Reddy A. K., Dakshinamurty K. V., Lakshmi V. Utility of HCV core antigen ELISA in the screening for hepatitis C virus infection in patients on hemodialysis. Indian J Med Microbiol. 2006 Jan; 24 (1): 55-7.

3. Кудрявцева Е. Н., Корабельникова М. И., Красавченко К. С., Ястребова О. Н., Туманова О. Ю., Лебедева Е. И., Кузина Л. Е., Кицак В.Я, Калашникова А. С., Семененко Т. А., Кузин С. Н. О диагностической значимости определения CORE-антигена вируса гепатита С // Эпидемиология и вакцинопрофилактика. - 2013. - Том 6, № 73. - С. 32-36.

4. Barril G., Quiroga J. A., Arenas M. D., Espinosa M., Garcia-Fernandez N., Cigarran S., Her-rero J. A., del Peso G., Caro P., Garcia-Agudo R., Amézquita Y., Blanco A., Martfnez-Rubio P., Alcazar J. M., Gonzalez-Parra E., Martfn-Gômez A., Castillo I., Bartolomé J., Carreno V. Impact of isolated hepatitis C virus (HCV) core-specific antibody detection and viral RNA amplification among HCV-seronegative dialysis patients at risk for infection // J. Clin. Microbiol. - 2014. - 52 (8): 3053-6.doi: 10.1128/JCM.01339-14.

5. О применении в практике здравоохранения: приказ МЗ РФ № 322 от 21.10.2002 г.

6. Приказ МЗ РФ № 322 от 21.10.2002 г. «О применении в практике здравоохранения иммуноферментных тест-систем для выявления поверхностного антигена вируса гепатита В (HBsAg) и антител к вирусу гепатита С (анти-ВГС) в сыворотке крови человека». Ссылка активна на 15.02.2018. http://base.garant.ru/6963112.

7. Quiroga J.A., Castillo I., Llorente S., Bartolomé J., Barril G., Carreno V. Identification of serologically silent occult hepatitis C virus infection by detecting immunoglobulin G antibody to a dominant HCV core peptide epitope // J. Hepatol. 2009 Feb; 50 (2): 256-63. doi: 10.1016.

8. Leôn P.1, Lopez J. A., Elola C., Lee S. R., Calmann M., Echevarria J.M. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen. Vox Sang. 1998; 75 (1): 32-6.

9. Потапова А. А. Диагностическая значимость и интерпретация неоднозначных результатов исследования серологических маркеров вирусного гепатита С: дисс.. д-ра биол. наук / М., 2015. - 275 с.

10. Pereira F. M., Zarife M. A.S., Reis E. A.G., Reis M. G. Indeterminate RIBA results were associated with the absence of hepatitis C virus RNA (HCV-RNA) in blood donors. Rev Soc Bras Med Trop. 2014; 47 (1): 12-17.

11. Масалова О. В. Вирусный гепатит С: новые подходы к изучению патогенеза и разработка средств диагностики и профилактики: дисс.. д-ра биол. наук / М., 2011. - 336 с.

12. Yagci S., Padalko E. Comparison of Mono-lisa HCV Ag/Ab ULTRA with two anti-HCV assays for the detection of HCV infection in hospitalsetting // Curr. Microbiol. - 2012. - V. 64, № 2. - P. 148-151.